Kilitch Drugs (India) Rights Issue 2025 Details, Record Date, Issue Price

Kilitch Drugs (India) Rights Issue details are now available. The company is issuing 13,98,463 equity shares amounting Rs 49.93 crores. Kilitch Drugs (India) Rights issue price is Rs 357 per share, with face value of Rs 10 per share.

Kilitch Drugs (India) Rights Issue open date is July 23, 2025, and closing date is August 21, 2025. Kilitch Drugs (India) rights issue entitlement ratio is 2:23, which is 2 Rights Equity Shares for every 23 fully paid-up Equity Shares held on the record date.

Kilitch Drugs (India) Rights Issue record date is July 15, 2025. The last date to buy shares of Kilitch Drugs (India) is July 14, 2025. This rights Issue subscription status will be available soon.

Kilitch Drugs (India) Rights Issue Allotment date is August 22, 2025, Credit of share date is August 25, 2025 and the Listing date is August 26, 2025. However, the listing will be on the BSE and NSE platforms.

Kilitch Drugs (India) rights issue registrar is MUFG Intime India Private Limited and the book-running lead manager(s) has not yet been disclosed.

Also Read | JMJ Fintech Rights Issue 2025 Details, Record Date, Issue Price

Kilitch Drugs (India) Rights Issue Details

Kilitch Drugs (India) Rights Issue details are as follows: the company plans to issue 13,98,463 equity shares, aggregating the amount of Rs 49.93 crores. Kilitch Drugs (India) Rights issue price is Rs 357 per share. The rights issue entitlement ratio is 2:23, which is 2 Rights Equity Share(s) for every 23 fully paid-up equity share(s).

Kilitch Drugs (India) Rights Issue Dates

Kilitch Drugs (India) Rights issue record date is July 15, 2025, and the last date to buy shares of Kilitch Drugs (India) is July 14, 2025.

Kilitch Drugs (India) Rights Issue Subscription

Kilitch Drugs (India) Rights Issue subscription status will be available soon. The details of Rights Issue entitlement are 2 Rights Equity Share(s) for every 23 fully paid-up Equity Share(s) held on Record Date. Kilitch Drugs (India) issue price is Rs 357 per share.

Kilitch Drugs (India) Limited: About the Company

Kilitch Drugs (India) Limited started back in 1978 and operates out of Mumbai. Over the decades, company have grown into a pharmaceutical company that makes all sorts of medicines - tablets, capsules, injections, syrups, creams, you name it.

What's interesting about Kilitch is how much they export. The company ship their products to over 38 countries, with Africa being a major market for them. They've got partnerships there and really understand those markets well. The factories have gotten approval from WHO and other international bodies, which is important when you're selling medicines globally.

Kilitch Drugs (India) have a wide variety of products. There are injectable drugs, nasal sprays, regular pills, fizzy tablets, nutritional products, and even some medical devices and cosmetic-type products. They cover treatments for stomach problems, infections, cancer, and lots of other conditions.

Company focuses on developing new products and building relationships with partners around the world. They're always looking at ways to get better healthcare products to people, whether that's in India or in markets overseas. It's been working for them - they've managed to stay relevant in a competitive industry for over 40 years now.

Kilitch Drugs (India) Limited Financials (Amount in Rs crore)

Kilitch Drugs (India) Rights Issue Registrar

Kilitch Drugs (India) rights issue registrar is MUFG Intime India Private Limited and the book-running lead manager(s) for this rights issue will be available soon.

FAQs

1. What are the details of the Kilitch Drugs (India) Rights Issue?

Kilitch Drugs (India) Rights Issue details available: Kilitch Drugs (India) is about to issue 13,98,463 equity shares amounting Rs 49.93 crores. Kilitch Drugs (India) Rights issue price is Rs 357 per share, with face value of Rs 10 per share. Rights issue entitlement ratio for this rights issue is 2:23, which is 2 Rights Equity Share(s) for every 23 fully paid-up equity share(s).

2. Kilitch Drugs (India) Rights Issue open date and close date?

Kilitch Drugs (India) Rights Issue open date is July 23, 2025, and closing date is August 21, 2025. Kilitch Drugs (India) Rights Issue record date is July 15, 2025, and the last date to buy shares of Kilitch Drugs (India) is July 14, 2025.

3. How can I apply for the Kilitch Drugs (India) Rights Issue?

You can apply for Kilitch Drugs (India) in two ways: one is Net Banking (ASBA), and the other is by visiting the Registrar's Website (R-WAP Facility).

4. What is the entitlement ratio for the Kilitch Drugs (India) Rights Issue?

Kilitch Drugs (India) rights issue entitlement ratio is 2:23, which is 2 Rights Equity Share(s) for every 23 fully paid-up equity share(s).

5. How can I check the Kilitch Drugs (India) Issue Allotment Status?

Kilitch Drugs (India) rights issue registrar is MUFG Intime India Private Limited. On the allotment status date investors can check their allotment status by visiting the registrar's website.

6. From where can I get the Letter of Offer Kilitch Drugs (India) Rights issue?

You can download the Kilitch Drugs (India) Rights issue Letter of Offer by visiting here.

7. What is the listing date of the Kilitch Drugs (India) Rights Issue?

The Kilitch Drugs (India) Rights Issue listing date is August 26, 2025. However, the listing will be on the NSE and BSE exchanges.

8. Who are the registrar and lead managers of the Kilitch Drugs (India) Rights Issue?

Kilitch Drugs (India) Limited's rights issue registrar is MUFG Intime India Private Limited and the book-running lead manager(s) for this rights issue have not yet been disclosed.

Also Read | Exicom Tele-Systems Rights Issue 2025 Details, Record Date, Issue Price